1. Home
  2. VKTX vs NATL Comparison

VKTX vs NATL Comparison

Compare VKTX & NATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viking Therapeutics Inc.

VKTX

Viking Therapeutics Inc.

HOLD

Current Price

$35.08

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Logo NCR Atleos Corporation

NATL

NCR Atleos Corporation

HOLD

Current Price

$43.70

Market Cap

3.0B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
VKTX
NATL
Founded
2012
2023
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.0B
IPO Year
2014
2023

Fundamental Metrics

Financial Performance
Metric
VKTX
NATL
Price
$35.08
$43.70
Analyst Decision
Strong Buy
Hold
Analyst Count
10
4
Target Price
$88.00
$45.60
AVG Volume (30 Days)
2.3M
1.2M
Earning Date
04-22-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.98
EPS
N/A
2.14
Revenue
N/A
$4,354,000,000.00
Revenue This Year
N/A
$6.13
Revenue Next Year
N/A
$4.24
P/E Ratio
N/A
$20.44
Revenue Growth
N/A
0.86
52 Week Low
$18.92
$22.30
52 Week High
$43.15
$48.50

Technical Indicators

Market Signals
Indicator
VKTX
NATL
Relative Strength Index (RSI) 56.38 53.05
Support Level $33.65 $42.03
Resistance Level $36.23 $48.50
Average True Range (ATR) 1.98 0.96
MACD -0.07 -0.18
Stochastic Oscillator 77.05 61.62

Price Performance

Historical Comparison
VKTX
NATL

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

Share on Social Networks: